- Medical Cannabis Home
- For Patients
- For Caregivers
- For Health Care Practitioners
- For Public Safety
- Laws and Rules
- Print Materials and Forms
- Registry Login/Create Account
- Petitions Process
- Data and Reports
- About the Medical Cannabis Program
Scientific Articles and Posters
The Office of Medical Cannabis has a goal to add to the scientific literature about medical cannabis. OMC shares non-identifiable data (patient names or other identifiable information are not shared) with external researchers to increase the scientific literature about medical cannabis use.
OMC staff work with external researchers to publish articles in peer-reviewed journals and other publications. Below is a sample of published articles where OMC staff are co-authors.
- Authors: Susan Anderson (Park), Dylan Zylla, Deepa McGriff, Tom Arneson
- Within four months of starting medical cannabis, patients enrolled in Minnesota’s Medical Cannabis Program saw significant relief from anxiety, depression, fatigue, nausea, pain, and vomiting, as well as increased appetite and better sleep. The findings were published in the Journal of Oncology Practice.
- Authors: Dylan Zylla, Justin Eklund, Grace Gilmore, Alissa Gavenda, Jordan Guggisberg, Gabriela VazquezBenitez, Pamala Pawloski, Tom Arneson, Sara Richter, Angela Birnbaum, Stephen Dahmer, Matthew Tracy, Arkadiusz Dudek
- Conducting randomized controlled trials using a state cannabis program is feasible. The addition of medical cannabis to standard oncology care was well-tolerated and may lead to improved pain control and lower opioid requirements. Conducting larger randomized controlled trials with medical cannabis in state-sponsored programs may guide oncology providers on how to safely and effectively incorporate medical cannabis for interested patients. The findings were published in Support Cancer Care.
- Authors: Dylan Zylla, Grant Steele, Justin Eklund, Jeanne Mettner, Tom Arneson
- Although support for cannabis use in the cancer setting is growing, significant barriers remain. This study illustrates a clear need to give clinicians both data and education to guide their discussions about the benefits, risks, and cost considerations of using medical cannabis for cancer-related symptoms. The findings were published in Cannabis and Cannabinoid Research.
- Authors: Deepa McGriff, Susan Anderson (Park), Tom Arneson
- This article describes preliminary findings from the Office of Medical Cannabis’ research about who is using the program and whether patients and their certifying health care practitioners are noticing benefits and harms. The article was published in Minnesota Medicine.
External researchers also develop and present scientific posters on studies using non-identifiable data from the Minnesota Medical Cannabis Program.
- Authors: Apoorva Reddy, Janvi Shah, John Hampton, Natalie Schmitz, Amy Trentham-Dietz
- The poster highlights the data analysis of a study to identify promising doses and cannabinoid products associated with improved symptoms in cancer survivors. The poster was presented at the American Academy of Hospice and Palliative Medicine and at Northern Michigan University.